World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0003608534
Reproduction Date:

Title: Crocetin  
Author: World Heritage Encyclopedia
Language: English
Subject: Saffron, Carotenoids, Crocin, Oxygen diffusion-enhancing compound, Gardenia jasminoides
Collection: Carotenoids, Dicarboxylic Acids, Nmda Receptor Antagonists, Saffron
Publisher: World Heritage Encyclopedia


Skeletal formula of crocetin
Ball and stick model of crocetin
IUPAC name
(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-Tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioic acid[2]
Other names
8,8'-Diapocarotenedioic acid;[1] Transcrocetinate
(sodium salt) N
ChemSpider  Y
EC number 248-708-0
Jmol-3D images Image
Molar mass 328.41 g·mol−1
Appearance Red crystals
Melting point 285 °C (545 °F; 558 K)
log P 4.312
Acidity (pKa) 4.39
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
 N  (: Y/N?)

Crocetin is a natural carotenoid dicarboxylic acid that is found in the crocus flower and Gardenia jasminoides[3] (fruits). It forms brick red crystals with a melting point of 285 °C.

The chemical structure of crocetin forms the central core of crocin, the compound responsible for the color of saffron.


  • Cell studies 1
  • Physiological effects 2
  • Transcrocetinate sodium 3
    • Mechanism of action 3.1
  • References 4

Cell studies

Crocin and crocetin may provide neuroprotection in rats by reducing the production of various neurotoxic molecules, based on an in-vitro cell study.[4]

Physiological effects

A 2009 study involving 14 individuals indicated that oral administration of crocetin may decrease the effects of physical fatigue in healthy men.[5]

A 2010 pilot study investigated the effect of crocetin on sleep. The clinical trial comprised a double-blind, placebo-controlled, crossover trial of 21 healthy adult men with a mild sleep complaint. It concluded that crocetin may (p=0.025) contribute to improving the quality of sleep.[6]

In high concentrations, it has protective effects against retinal damage in vitro and in vivo.[7]

Transcrocetinate sodium

The sodium salt of crocetin, transcrocetinate sodium (INN, also known as trans sodium crocetinate or TSC) is an experimental drug that increases the movement of oxygen from red blood cells into hypoxic (oxygen-starved) tissues.[8] Transcrocetinate sodium belongs to a group of substances known as bipolar trans carotenoid salts, which constitute a subclass of oxygen diffusion-enhancing compounds.[9] Transcrocetinate sodium was one of the first such compounds discovered.[8][10]

Transcrocetinate sodium

Transcrocetinate sodium can be prepared by reacting saffron with sodium hydroxide and extracting the salt of the trans crocetin isomer from the solution.[10] John L. Gainer and colleagues have investigated the effects of transcrocetinate sodium in animal models.[10][11] They discovered that the drug could reverse the potentially fatal decrease in blood pressure produced by the loss of large volumes of blood in severe hemorrhage, and thereby improve survival.[11]

Early investigations of transcrocetinate sodium suggested that it had potential applications in battlefield medicine, specifically in treatment of the many combat casualties with hemorrhagic shock.[8][11] Additional studies, carried out in animal models and in clinical trials in humans, indicated that transcrocetinate sodium might prove beneficial in the treatment of a variety of conditions associated with hypoxia and ischemia (a lack of oxygen reaching the tissues, usually due to a disruption in the circulatory system), including cancer, myocardial infarction (heart attack), and stroke.[8][9][12][13][14]

Transcrocetinate sodium has shown promise of effectiveness in restoring tissue oxygen levels and improving the ability to walk in a clinical trial of patients with peripheral artery disease (PAD)[13] in which reduced delivery of oxygen-rich blood to tissues can cause severe leg pain and impair mobility. The drug has also been under investigation in a clinical trial sponsored by drug developer Diffusion Pharmaceuticals for potential use as a radiosensitizer, increasing the susceptibility of hypoxic cancer cells to radiation therapy, in patients with a form of brain cancer known as glioblastoma.[14]

Mechanism of action

Similar to other

  1. ^ a b Merck Index, 11th Edition, 2592
  2. ^ PubChem 5281232
  3. ^ Umigai N, Murakami K, Ulit MV; et al. (May 2011). "The pharmacokinetic profile of crocetin in healthy adult human volunteers after a single oral administration". Phytomedicine 18 (7): 575–8.  
  4. ^ Nam KN, Park Y-M, Jung H-J, Lee JY, Min BD, Park S-U, Jung W-S, Cho K-H, Park J-H, Kang I, Hong J-W, Lee EH (2010). "Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells.".  
  5. ^ Mizuma H, Tanaka M, Nozaki S, Mizuno K, Tahara T, Ataka S, Sugino T, Shirai T, Kajimoto Y, Kuratsune H, Kajimoto O, Watanabe Y (March 2009). "Daily oral administration of crocetin attenuates physical fatigue in human subjects". Nutrition Research 29 (3): 145–50.  
  6. ^ Kuratsune H, Umigai N, Takeno R, Kajimoto Y, Nakano T (September 2010). Ellis on sleep: a pilot study"Gardenia jasminoides"Effect of crocetin from . Phytomedicine 17 (11): 840–3.  
  7. ^ Yamauchi, M; Tsuruma, K; Imai, S; Nakanishi, T; Umigai, N; Shimazawa, M; Hara, H (2011). "Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity". European Journal of Pharmacology 650 (1): 110–9.  
  8. ^ a b c d Gainer, J (2008). "Trans-sodium crocetinate for treating hypoxia/ischemia". Expert Opinion in Investigational Drugs 17 (6): 917–924.  
  9. ^ a b US patent 8,206,751, Gainer J, "New Class of Therapeutics that Enhance Small Molecule Diffusion", issued 2009-04-30 
  10. ^ a b c US patent 6,060,511, Gainer J, "Trans-sodium crocetinate, methods of making and methods of use thereof", issued 2000-05-09 
  11. ^ a b c Giassi L; et al. (2001). "Trans-Sodium Crocetinate Restores Blood Pressure, Heart Rate, and Plasma Lactate after Hemorrhagic Shock". Journal of Trauma-Injury Infection & Critical Care 55 (5): 932–938.  
  12. ^ Lapchak P, (2010). "Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: A combination therapy study with tissue plasminogen activator". Brain Research 1309: 136–145.  
  13. ^ a b Mohler E; et al. (2010). "Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication". Vascular Medicine 16 (5): 346–352.  
  14. ^ a b "Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) With Concomitant Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM)".  
  15. ^ a b Stennett a; et al. (2006). "Trans sodium crocetinate and diffusion enhancement". Physical Chemistry B 110: 18078–18080.  
  16. ^ Laidig, K.E., J.L. Gainer, V. Daggett (1998). "Altering Diffusivity in Biological Solutions through Modification of Solution Structure and Dynamics". Journal of the American Chemical Society 120 (36): 9394–9395.  
  17. ^ Manabe H; et al. (2010). "Protection against focal ischemic injury to the brain by trans-sodium crocetinate". Journal of Neurosurgery 113 (4): 802–809.  
  18. ^ Berger F, Hensel A, Nieber K (2011). "Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices". Neuroscience 180: 238–47.  
  19. ^ Lautenschläger M, Lechtenberg M, Sendker J, Hensel A (2014). "Effective isolation protocol for secondary metabolites from saffron: semi-preparative scale preparation of crocin-1 and trans-crocetin". Fitoterapia 92: 290–5.  
  20. ^ Lautenschläger M, Sendker J, Hüwel S, Galla HJ, Brandt S, Düfer M, Riehemann K, Hensel A (2015). "Intestinal formation of trans-crocetin from saffron extract (Crocus sativus L.) and in vitro permeation through intestinal and blood brain barrier". Phytomedicine 22 (1): 36–44.  


Trans-crocetin has been found to act as an NMDA receptor antagonist with high affinity, and has been implicated in the psychoactivity of Saffron.[18][19][20]


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.